Enhancing Pricing Analogues with the Epidemiological Data to Justify Price Point Among a Small Population
Time: 2:30 pm
day: Conference Day One
Details:
- Using epidemiological data to refine pricing analogues and ensure the price point aligns with patient population size and unmet needs
- Leveraging historical pricing trends and real-world evidence to support pricing decisions for rare diseases while addressing payer concerns
- Demonstrating the long-term value of treatments through clear data on patient outcomes and cost-effectiveness, even for small patient populations
